Canopy Growth Corporation
CGC
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $410.6M
$0.97
▼ -0.02%
P/E
-2.27
Mkt Cap
$410.6M
52-Wk Range
$0.84–$2.38
52-Week Range
$0.84 - $2.38
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 27.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Established multi-brand portfolio with strong consumer recognition
- Vertically integrated supply chain and distribution network
- First-mover advantage in regulated cannabis markets
- International presence across key markets (Canada, US, Germany)
Bear Case
1 risk
- High volatility (beta 2.4). Larger-than-normal price swings expected.
Growth
Revenue decline expected
Expansion of U.S. cannabis legalization and market access
Value
Deep value opportunity - significant discount to Large Cap Pharma peers
Momentum
Stable
-4.6% over 3m
Quality
Stable
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying CGC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 6, 2026
AUG 7, 2026
Reported EPS of -$0.02 vs -$0.04 consensus (+50.0% surprise). Revenue of $57.1M vs $58.2M expected (-1.8%).
EPS surprise · last 4Q
1 of 2 beats
Estimate
Actual
Q3 26
+50.0%
Q2 26
-183.3%
Revenue trend · last 8Q
—
—
—
-11%
+9%
+6%
-0%
-9%
Q1 24
Q2 24
Q3 24
Q4 25
Q1 25
Q2 25
Q3 25
Q1 27
$66.2M
$63.0M
$74.8M
$65.0M
$72.1M
$66.7M
$74.5M
$59.0M
Margins · last 8Q
Gross
—
Operating
—
Profit
-18.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How CGC stacks vs Drug Manufacturers - Specialty & Generic
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related